CLSI EP19 : 2ED 2015
|
A FRAMEWORK FOR USING CLSI DOCUMENTS TO EVALUATE CLINICAL LABORATORY MEASUREMENT PROCEDURES
|
CLSI EP18 P2 : 2ED 2007
|
RISK MANAGEMENT TECHNIQUES TO IDENTIFY AND CONTROL LABORATORY ERROR SOURCES
|
CLSI H48 : 2ED 2016
|
DETERMINATION OF COAGULATION FACTOR ACTIVITIES USING THE ONE-STAGE CLOTTING ASSAY
|
CLSI EP18 A2 : 2ED 2009
|
RISK MANAGEMENT TECHNIQUES TO IDENTIFY AND CONTROL LABORATORY ERROR SOURCES
|
CLSI EP25 A : 1ED 2009
|
EVALUATION OF STABILITY OF IN VITRO DIAGNOSTIC REAGENTS
|
CLSI EP29 A : 1ED 2012
|
EXPRESSION OF MEASUREMENT UNCERTAINTY IN LABORATORY MEDICINE
|
CLSI POCT12 A3 : 3ED 2013
|
Point-of-Care Blood Glucose Testing in Acute and Chronic Care Facilities; Approved Guideline—Third Edition<br>
|
CLSI POCT7 A :2010(R2018)
|
Validation and Verification of Tubes for Venous and Capillary Blood Specimen Collection
|
CLSI EP18 P3 : 3ED 2009
|
RISK MANAGEMENT TECHNIQUES TO IDENTIFY AND CONTROL LABORATORY ERROR SOURCES
|
CLSI H26 P2 : 2ED 2009
|
VALIDATION, VERIFICATION, AND QUALITY ASSURANCE OF AUTOMATED HEMATOLOGY ANALYZERS
|
CLSI EP27 P : 1ED 2009
|
HOW TO CONSTRUCT AND INTERPRET AN ERROR GRID FOR DIAGNOSTIC ASSAYS
|
CLSI H57 A : 1ED 2008
|
PROTOCOL FOR THE EVALUATION, VALIDATION, AND IMPLEMENTATION OF COAGULOMETERS
|
CLSI C52 A2 : 2ED 2007
|
TOXICOLOGY AND DRUG TESTING IN THE CLINICAL LABORATORY
|
CLSI GP34 P : 1ED 2009
|
VALIDATION AND VERIFICATION OF TUBES FOR VENOUS AND CAPILLARY BLOOD SPECIMEN COLLECTION
|
CLSI I/LA32 P : 1ED 2009
|
NEWBORN SCREENING BY TANDEM MASS SPECTROMETRY
|
CLSI I/LA34 P : 1ED 2010
|
DESIGN AND VALIDATION OF IMMUNOASSAYS FOR ASSESSMENT OF HUMAN ALLERGENICITY OF NEW BIOTHERAPEUTIC DRUGS
|
CLSI MM6 A2 : 2ED 2010
|
QUANTITATIVE MOLECULAR METHODS FOR INFECTIOUS DISEASES
|
CLSI C34 A3 : 3ED 2009
|
SWEAT TESTING: SAMPLE COLLECTION AND QUANTITATIVE CHLORIDE ANALYSIS
|
CLSI H20 A2 : 2ED 2007
|
Reference Leukocyte (WBC) Differential Count (Proportional) and Evaluation of Instrumental Methods, 2nd Edition<br>
|
CLSI MM19 P : 1ED 2011
|
ESTABLISHING MOLECULAR TESTING IN CLINICAL LABORATORY ENVIRONMENTS
|
CLSI NBS05 A : 1ED 2011
|
NEWBORN SCREENING FOR CYSTIC FIBROSIS
|
CLSI C57 : 1ED 2015
|
MASS SPECTROMETRY FOR ANDROGEN AND ESTROGEN MEASUREMENTS IN SERUM
|
CLSI H57 P : 1ED 2007
|
PROTOCOL FOR THE EVALUATION, VALIDATION, AND IMPLEMENTATION OF COAGULOMETERS
|
CLSI NBS04 A : 1ED 2010
|
NEWBORN SCREENING BY TANDEM MASS SPECTROMETRY<br>
|
CLSI MM19 A : 1ED 2011
|
ESTABLISHING MOLECULAR TESTING IN CLINICAL LABORATORY ENVIRONMENTS
|
CLSI EP15 A3 : 3ED 2014
|
USER VERIFICATION OF PRECISION AND ESTIMATION OF BIAS
|
CLSI QMS01 A4 : 4ED 2011
|
QUALITY MANAGEMENT SYSTEM: A MODEL FOR LABORATORY SERVICES
|
CLSI GP34 A : 1ED 2010
|
VALIDATION AND VERIFICATION OF TUBES FOR VENOUS AND CAPILLARY BLOOD SPECIMEN COLLECTION
|
CLSI GP16-A3 : 2009
|
Urinalysis; Approved Guideline—Third Edition
|
CLSI EP5 A3 : 3ED 2014
|
Evaluation of Precision of Quantitative Measurement Procedures; Approved Guideline—Third Edition<br>
|
CLSI I/LA20 A2 : 2ED 2009
|
ANALYTICAL PERFORMANCE CHARACTERISTICS AND CLINICAL UTILITY OF IMMUNOLOGICAL ASSAYS FOR HUMAN IMMUNOGLOBULIN E (IGE) ANTIBODIES AND DEFINED ALLERGEN SPECIFICITIES
|
CLSI EP22 P : 1ED 2010
|
PRESENTATION OF A MANUFACTURER'S RISK MITIGATION INFORMATION FOR USERS OF IN VITRO DIAGNOSTIC DEVICES
|
CLSI C50 A : 1ED 2007
|
MASS SPECTROMETRY IN THE CLINICAL LABORATORY: GENERAL PRINCIPLES AND GUIDANCE
|